Inducible Cre Recombination in Transgenic Mice
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : University College London, Wolfson Foundation
Protocol cited in 30 other protocols
Variable analysis
- Tamoxifen administration
- Timing of tamoxifen administration (P45 or P180)
- Percentage of PDGFRA+ OLPs labeled for YFP in the corpus callosum
- Percentage of PDGFRA+ OLPs labeled for YFP in the medial cortex
- Proportion of cells (including GFAP+ type-B cells) in the forebrain SVZ labeled for YFP
- Proportion of Fgfr3-expressing astrocytes in the parenchyma labeled for YFP
- Homozygous creERT2 mouse lines maintained on the Rosa26-YFP reporter background
- Practically all cells in the forebrain SVZ (including GFAP+ type-B cells) and a high proportion of Fgfr3-expressing astrocytes in the parenchyma labeled for YFP in Fgfr3-icreERT2/Rosa26-YFP mice
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!